Monica Longo 1 , Jerrie S Refuerzo 1 , Lovepreet Mann 1 , Mateo Leon 1 , Hind N Moussa 1 , Baha M Sibai 1 , Sean C Blackwell 1 . Show Affiliations »
Abstract
BACKGROUND: We previously reported that offspring heterozygous mice partially lacking endothelial nitric oxide synthase (eNOS) gene, and born to hypertensive eNOS-/- Knockout mother, are hypertensive. We hypothesized that those offspring when placed on high-fat diet (HFD) will undergo altered metabolic programming increasing their risk for developing metabolic syndrome. METHODS: eNOS-/-KO and wild-type mice (eNOS+/+WT) were cross-bred to produce heterozygous offspring: maternal heterozygous (Mat, eNOS-/+), born from hypertensive eNOS-/-KO mothers; and paternal heterozygous (Pat, eNOS-/+), born from normotensive WT mothers. Mat, eNOS-/+ and Pat, eNOS-/+ female were allocated to HFD or control diet (CD) until 8 weeks of age. Then a metabolic profile was obtained: weight, glucose/insulin tolerance test (GTT, ITT), systolic blood pressure (SBP), serum fasting levels of insulin, adiponectin, leptin, and a lipid panel. RESULTS: Weight was not different between all offspring within each diet. GTT curve was higher in Mat, eNOS-/+ vs. Pat, eNOS-/+ offspring on both diet (P < 0.001). In ITT, glucose level at 15 minutes was higher in Mat, eNOS-/+ on HFD. Insulin level was increased in Mat, eNOS-/+ vs. Pat, eNOS-/+ on either diet. SBP was elevated in Mat, eNOS-/+ vs. Pat, eNOS-/+ on CD and was further raised in Mat, eNOS-/+ offspring on HFD (P < 0.001). No other differences were seen except for lower high-density lipoprotein levels in Mat, eNOS-/+ fed HFD (P < 0.003). CONCLUSIONS: Mat, eNOS-/+ offspring exposed in utero to maternal hypertension and fed HFD postnatally have increased susceptibility for metabolic abnormalities. Thus, maternal HTN is a risk factor for altered fetal metabolic programming. © American Journal of Hypertension, Ltd 2016. All rights reserved. For Permissions, please email: journals.permissions@oup.com
BACKGROUND: We previously reported that offspring heterozygous mice partially lacking endothelial nitric oxide synthase (eNOS ) gene, and born to hypertensive eNOS -/- Knockout mother, are hypertensive . We hypothesized that those offspring when placed on high-fat diet (HFD) will undergo altered metabolic programming increasing their risk for developing metabolic syndrome . METHODS: eNOS -/-KO and wild-type mice (eNOS +/+WT) were cross-bred to produce heterozygous offspring: maternal heterozygous (Mat, eNOS -/+), born from hypertensive eNOS -/-KO mothers; and paternal heterozygous (Pat, eNOS -/+), born from normotensive WT mothers. Mat, eNOS -/+ and Pat, eNOS -/+ female were allocated to HFD or control diet (CD ) until 8 weeks of age. Then a metabolic profile was obtained: weight, glucose/insulin tolerance test (GTT, ITT), systolic blood pressure (SBP), serum fasting levels of insulin, adiponectin , leptin , and a lipid panel. RESULTS: Weight was not different between all offspring within each diet. GTT curve was higher in Mat, eNOS -/+ vs. Pat, eNOS -/+ offspring on both diet (P < 0.001). In ITT, glucose level at 15 minutes was higher in Mat, eNOS -/+ on HFD. Insulin level was increased in Mat, eNOS -/+ vs. Pat, eNOS -/+ on either diet. SBP was elevated in Mat, eNOS -/+ vs. Pat, eNOS -/+ on CD and was further raised in Mat, eNOS -/+ offspring on HFD (P < 0.001). No other differences were seen except for lower high-density lipoprotein levels in Mat, eNOS -/+ fed HFD (P < 0.003). CONCLUSIONS: Mat, eNOS -/+ offspring exposed in utero to maternal hypertension and fed HFD postnatally have increased susceptibility for metabolic abnormalities . Thus, maternal HTN is a risk factor for altered fetal metabolic programming. © American Journal of Hypertension , Ltd 2016. All rights reserved. For Permissions, please email: journals.permissions@oup.com
Entities: Chemical
Disease
Gene
Species
Keywords:
blood pressure; fetal programming; hypertension; maternal hypertension; metabolic syndrome; obesogenic diet; uterine environment.
Mesh: See more »
Substances: See more »
Year: 2016
PMID: 27565786 DOI: 10.1093/ajh/hpw088
Source DB: PubMed Journal: Am J Hypertens ISSN: 0895-7061 Impact factor: 2.689